Medicare Just Rewrote the TAVR Rulebook: What Changed, What Didn’t, and What It Means for Your Practice
Section analysis by Tatyana Kantor, Billing Department, WCH
Editorial note: This article draws on the CMS final decision memo for transcatheter aortic valve replacement (TAVR), CAG-00430R2, and reporting and statements from the American College of Cardiology (ACC), the Society of Thoracic Surgeons (STS), the Society for Cardiovascular Angiography and Interventions (SCAI), and specialty trade press, current through September 2026. It is for informational and educational purposes only and does not constitute legal, coding, or compliance advice.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
